NICE endorses breast-cancer metastasis analyzer from Sysmex

08/8/2013 | Clinica (subscription required)

Sysmex has received endorsement from the U.K.'s National Institute for Health and Care Excellence for its RD-100i OSNA technology. The recommendation applies for use of the device in diagnosing sentinel lymph node metastases in patients undergoing initial breast cancer surgery.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC